JadChahoudMD

Medical Director of IPOP, Moffitt Cancer Center, Assistant Professor, Morsani College of Medicine

Telehealth Available

Overview of Dr. Chahoud

Dr. Jad Chahoud is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Lebanese University School of Medicine and has been in practice 4 years. He is one of 47 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Hematology. He also speaks multiple languages, including Arabic, French, and Spanish. He has more than 80 publications and over 500 citings.

Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Book by Phone+1(229) 597-3227

Fax+1 813-449-8453

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2014 - 2016
The University of Massachusetts, AmherstMPH, 2014 - 2016
University of MassachusettsMPH, 2014 - 2016
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Internal Medicine, 2013 - 2014
Lebanese University School of MedicineClass of 2012

Certifications & Licensure

FL State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Best Abstract-Young Investigator Award (ASCO) Conquer Cancer 2020 Scientific and Career Development-, 2020
The William L. Pippin, Jr. Fellowship in Genitourinary Cancer Research The University of Texas MD Anderson Cancer Center, 2019
Conquer Cancer Foundation Merit Award The American Society of Oncology (ASCO), 2018
Outstanding Fellow Award Texas Society of Clinical Oncology, 2018
2018 Conquer Cancer Foundation Young Investigator Award (YIA) The American Society of Oncology (ASCO), 2018
Conquer Cancer Foundation Merit Award The American Society of Clinical Oncology (ASCO), 2018
Join now to see all

Publications & Presentations

PubMed

Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas.
Justin W Miller, Jeffrey S Johnson, Christopher Guske, Gowtam Mannam, Firas Hatoum
Cancers. 2025-01-20
Belzutifan for renal cell carcinoma: Balancing regulatory approval with societal and patient impact.
Jad Chahoud, Pavlos Msaouel
Med. 2025-01-10
The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis.
Arfa Mustasam, Kevin Parza, Filip Ionescu, Keerthi Gullapalli, Mahati Paravathaneni
Journal of the National Comprehensive Cancer Network. 2025-01-03

Lectures

Nivolumab (nivo) for patients (pts) with metastatic non-clear cell renal cell carcinoma (nccRCC): A single-institution experience.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Patients’ Voices Largely Absent from FDA Reviews of New Cancer DrugsApril 24th, 2024
Study Suggests Improvements Needed for Patient-Reported Outcome Data in Genitourinary Cancer Clinical StudiesFebruary 7th, 2024
Moffitt Study Finds Neoadjuvant Chemotherapy Significantly Improves Outcomes for Penile Squamous Cell Carcinoma PatientsFebruary 23rd, 2024